The present disclosure relates to tungsten complexes, catalyst systems including tungsten complexes, and polymerization processes to produce polycycloolefin polymers such as polycyclopentene polymers and polycyclooctene polymers.

Described herein is a method for obtaining a selective estrogen receptor degrader, and compounds used in preparing the selective estrogen receptor degrader.

A method for producing a carbamic acid salt, including contacting a carbon dioxide-containing mixed gas having a partial pressure of carbon dioxide of 0.001 atm or more and less than 1 atm with an amino group-containing organic compound in the presence of a base in at least one organic solvent selected from the group consisting of an organic solvent having 2 or more and 8 or less carbon atoms, and a method for producing a carbamic acid ester or a urea derivative using the carbamic acid salt.

A method for preparing an aldehyde including forming a reaction product including an aldehyde by reacting an olefin-based compound with a synthetic gas in a hydroformylation reactor in the presence of a hydroformylation catalyst; introducing the reaction product including the aldehyde to a vaporizer; separating low-boiling point components of the reaction product from an upper part of a vaporizer catch pot included in the vaporizer; separating high-boiling point components of the reaction product from a lower part of the vaporizer catch pot; and recirculating at least a portion of the low-boiling point components separated from an upper part of the vaporizer catch pot back to the vaporizer.

A halosilane compound: R.sup.1CH.sub.2CH.sub.2SiR.sup.5.sub.2X is prepared by hydrosilylation reaction of a vinyl compound: R.sup.1CH═CH.sub.2 with a halogenodiorganosilane compound having formula: HSiR.sup.5.sub.2X in the co-presence of an iridium catalyst, an internal olefin compound, and an allyl halide. The halosilane compound is prepared on an industrial scale with the advantages of low costs, high yields, and high selectivity, using a small amount of iridium catalyst.

Nanoparticles that can be used as hydrosilylation and dehydrogenative silylation catalysts. The nanoparticles have at least one transition metal with an oxidation state of 0, chosen from the metals of columns 8, 9 and 10 of the periodic table, and at least one carbonyl ligand, preferably a silicide.

Provided herein is a process for synthesis of intermediates for ipatasertib related to large scale manufacture of (R)-5-methyl-4-(piperazin-1-yl)-5,6-dihydro-7H-cyclopenta[d]pyrimidin-7-one.

The present invention relates to a process for preparing the Alectinib or a pharmaceutically acceptable salt thereof using lesser reaction steps and also eliminating expensive and time-consuming column chromatography. The invention also relates to novel polymorphic forms of Alectinib and Alectinib hydrochloride.

A method for dehydrocoupling silanes and amines. The method comprises contacting: (a) an aliphatic amine; (b) a silane; and (c) a catalyst which is ZnX.sub.2, wherein X is alkyl, chloride, bromide, iodide, trifluoromethanesulfonate, bis(trifluoromethane)sulfonamide, tosylate, methanesulfonate or O.sub.3S(CF.sub.2).sub.xCF.sub.3 wherein x is an integer from 1 to 10.

The alkylation of transition metal coordination catalyst complexes (such as metallocenes and/or post-metallocenes) in non-polar solvents with high conversion to the dialkylated transition metal coordination catalyst complex may be accomplished by reacting (a) a transition metal coordination catalyst complex comprising a transition metal linked to at least one an anionic donor ligand and at least one leaving group having a non-carbon atom directly linked to the transition metal, (b) an aluminum alkyl, and (c) a fluoride salt at 0° C. to 85° C. in a non-polar solvent to yield an alkylated transition metal coordination catalyst complex.